Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in Lymphocytic Myocarditis
NCT05237323Phase 3Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- Oct 2020
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in lymphocytic myocarditis, sponsored by Sechenov First Moscow State Medical University. Started Oct 2020; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
lymphocytic myocarditis
Beyond the preview
Go deeper on NCT05237323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237323.